Arnsdorf M F, Sawicki G J
The Department of Medicine, University of Chicago, Illinois.
J Pharmacol Exp Ther. 1989 Mar;248(3):1158-66.
Ethmozin is a phenothiazine derivative that is effective against supraventricular and ventricular arrhythmias. Studies to date have examined ethmozin's effects on active cellular properties and automaticity, but nothing is known of its effects on passive properties or on the interrelationships among the several active and passive properties that are of particular relevance to cardiac excitability. The hypothesis tested in this study was that ethmozin, in concentrations equivalent to clinically effective antiarrhythmic levels, would simultaneously affect passive and active cellular properties so as to produce a net decrease in cardiac excitability. The multiple micro-electrode method of intracellular constant current application and trans-membrane voltage recording was used in sheep Purkinje fibers to determine strength-duration and constant current-voltage relationships as well as cable properties. A rapid, on-line computerized data analysis system tracked in time the alterations in the active and passive properties relevant to excitability. Ethmozin, at concentrations of 1.1 and 2.2 microM (0.5 and 1.0 mg/l), decreased cardiac excitability as manifested by an increase in the current required to attain threshold and/or an upward shift in strength- and charge-duration relationships, by depressing the sodium system (decreased maximal rate of rise of phase 0 of the action potential, voltage threshold and overshoot), by decreasing slope resistance and altering nonlinearities of the current-voltage relationships in the subthreshold potential range, by decreasing membrane resistance and by affecting other properties dependent on membrane resistance which would depress excitability. The data for ethmozin and other antiarrhythmic drugs are interpreted in terms of the recently proposed electrophysiologic matrix which we believe has important advantages over traditional hierarchical classifications.
乙吗噻嗪是一种吩噻嗪衍生物,对室上性和室性心律失常有效。迄今为止的研究考察了乙吗噻嗪对细胞活性特性和自律性的影响,但对其对被动特性或对与心脏兴奋性特别相关的几种主动和被动特性之间的相互关系的影响尚不清楚。本研究检验的假设是,乙吗噻嗪在相当于临床有效抗心律失常水平的浓度下,会同时影响细胞的被动和主动特性,从而使心脏兴奋性净降低。在绵羊浦肯野纤维中采用细胞内恒流施加和跨膜电压记录的多微电极方法,以确定强度-时间和恒流-电压关系以及电缆特性。一个快速的在线计算机化数据分析系统及时跟踪与兴奋性相关的主动和被动特性的变化。乙吗噻嗪在浓度为1.1和2.2微摩尔/升(0.5和1.0毫克/升)时,降低了心脏兴奋性,表现为达到阈值所需电流增加和/或强度-时间和电荷-时间关系向上移位,通过抑制钠系统(动作电位0期最大上升速率、电压阈值和超射降低),通过降低斜率电阻和改变阈下电位范围内电流-电压关系的非线性,通过降低膜电阻以及通过影响其他依赖于膜电阻的特性,这些都会降低兴奋性。根据最近提出的电生理基质对乙吗噻嗪和其他抗心律失常药物的数据进行了解释,我们认为该基质比传统的分级分类具有重要优势。